NCT01114620View on ClinicalTrials.gov

Study of GSK Biologicals' Influenza Vaccine Arepanrix™ in Japanese Adults 65 Years of Age or Older

PHASE4CompletedINTERVENTIONAL

Enrollment

50

Participants

Timeline

Start Date

May 17, 2010

Primary Completion Date

November 5, 2010

Study Completion Date

December 9, 2010

Conditions

Influenza

Interventions

BIOLOGICAL

Arepanrix™

Intramuscular administration, one dose

Trial Locations (1)

813-8588

GSK Investigational Site, Fukuoka

Sponsors

Lead Sponsor

GlaxoSmithKline

All Listed Sponsors

lead

GlaxoSmithKline

INDUSTRY

NCT01114620 - Study of GSK Biologicals' Influenza Vaccine Arepanrix™ in Japanese Adults 65 Years of Age or Older | Biotech Hunter | Biotech Hunter